- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-BMP7
BMP7 Polyclonal Antibody for IF/ICC, FC (Intra)
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, souris
Applications
IF/ICC, FC (Intra)
Conjugaison
CoraLite® Plus 488 Fluorescent Dye
N° de cat : CL488-12221
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en IF/ICC | cellules HeLa, |
| Résultats positifs en FC (Intra) | cellules HEK-293, |
Dilution recommandée
| Application | Dilution |
|---|---|
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.80 ug per 10^6 cells in a 100 µl suspension |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
CL488-12221 cible BMP7 dans les applications de IF/ICC, FC (Intra) et montre une réactivité avec des échantillons Humain, souris
| Réactivité | Humain, souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | BMP7 Protéine recombinante Ag2902 |
| Nom complet | bone morphogenetic protein 7 |
| Masse moléculaire calculée | 431 aa, 49 kDa |
| Poids moléculaire observé | 43-49 kDa |
| Numéro d’acquisition GenBank | BC008584 |
| Symbole du gène | BMP7 |
| Identification du gène (NCBI) | 655 |
| Conjugaison | CoraLite® Plus 488 Fluorescent Dye |
| Excitation/Emission maxima wavelengths | 493 nm / 522 nm |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA |
| Conditions de stockage | Stocker à -20 °C. Éviter toute exposition à la lumière. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
The bone morphogenetic proteins (BMPs) are a family of secreted signaling molecules that can induce ectopic bone growth. Many BMPs are part of the transforming growth factor-beta (TGFB) superfamily. BMPs were originally identified by an ability of demineralized bone extract to induce endochondral osteogenesis in vivo in an extraskeletal site.
BMP7, also known as osteogenic protein-1 or OP-1, plays a key role in the transformation of mesenchymal cells into bone and cartilage. BMP7 may be involved in bone homeostasis (PMID: 15621726). It is expressed in the brain, kidneys and bladder. BMP7 is also present in cancers, including breast, prostate, and colon cancers, in which it is implicated in regulating cancer cell proliferation (PMID: 16419056, PMID: 15531927). Overexpression of BMP7 mRNA in colorectal cancer patients was significantly associated with poor prognosis and low overall survival (PMID: 18259822). Recent studies suggest that high-expression level of BMP7 serves as a biomarker for poor prognosis for HCC (PMID: 23179403).
Protocole
| Product Specific Protocols | |
|---|---|
| IF protocol for CL Plus 488 BMP7 antibody CL488-12221 | Download protocol |
| FC protocol for CL Plus 488 BMP7 antibody CL488-12221 | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |

